How to Get Skyrizi (Risankizumab) Covered by Blue Cross Blue Shield of Illinois: Complete Prior Authorization and Appeals Guide
Quick Answer: Blue Cross Blue Shield of Illinois requires prior authorization for Skyrizi (risankizumab). Submit the Illinois Uniform PA Form through Prime Therapeutics with documented step therapy attempts. If denied, you have 180 days to appeal internally, then 4 months for Illinois external review. Start by calling the number on